Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Patent: 8,962,804

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,962,804
Title:Meditopes and meditope-binding antibodies and uses thereof
Abstract: Antibodies and meditopes that bind to the antibodies are provided, as well as complexes, compositions and combinations containing the meditopes and antibodies, and methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses.
Inventor(s): Williams; John C. (Monrovia, CA), Horne; David A. (Duarte, CA), Ma; Yuelong (Duarte, CA), Chang; Heng Wei (Foster City, CA), Donaldson; Joshua Michael (Lumberton, NJ), Zer; Cindy (Duarte, CA), Bzymek; Krzysztof (Pasadena, CA), Avery; Kendra Nicole (Pasadena, CA), Xie; Jun (Duarte, CA)
Assignee: City of Hope (Duarte, CA)
Application Number:13/443,804
Patent Claims:see list of patent claims

Details for Patent 8,962,804

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Centocor Ortho Biotech Products, L.p. ORTHOCLONE OKT3 muromanab-cd3 Injection 103463 1992-09-14 ⤷  Free Forever Trial 2030-10-08
Janssen Biotech, Inc. REOPRO abciximab Injection 103575 1994-12-22 ⤷  Free Forever Trial 2030-10-08
Aytu Bioscience, Inc. PROSTASCINT capromab pendetide Injection 103608 1996-10-28 ⤷  Free Forever Trial 2030-10-08
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Free Forever Trial 2030-10-08
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 2002-02-19 ⤷  Free Forever Trial 2030-10-08
Hoffmann-la Roche Inc. ZENAPAX daclizumab Injection 103749 1997-12-10 ⤷  Free Forever Trial 2030-10-08
Novartis Pharmaceuticals Corporation SIMULECT basiliximab For Injection 103764 1998-05-12 ⤷  Free Forever Trial 2030-10-08
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.